Dr. Law is also involved in Anticoagulation Monitoring Program and Drug Use Evaluation committee at CHOP. She completed training in LEAN, SIX SIGMA, and CHOP Improvement Leadership program. She actively participates in various process improvement and cost savings initiatives.
Anticoagulation
LEAN and SIX SIGMA
Pharmacoeconomics
Pharmacoinformatics
Pharmacy Practice (PGY1) - The Philadelphia Veterans Affair Medical Center, Philadelphia, PA
Drug Information Specialty (PGY2) - Thomas Jefferson University Hospital, Philadelphia, PA
Doctor of Pharmacy - University of the Sciences in Philadelphia (USIP), Philadelphia, PA
Residency Preceptor, Pharmacy Residency Program
Clinical Pharmacy Specialist in Drug Information and Policy Development
Statin therapy in HCV
Non-formulary medication management
Law C, Raffini. A guide to the use of anticoagulant drugs in children. Paediatr Drugs. 2015;17(2):105-14.
Greene LA, Law C, Jung M, Walton S, Ignjatovic V, Monagle P, Raffini LJ. Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 2014;12(9):1554-7.
McIntyre C, Law C, Erush S. Drug information skills: An abandoned necessity? AJHP 2014;71(11):900-1.
Bustin, A, Gomes J, Law C. Drug use evaluation of anakinra in a pediatric population. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.
Ciaramitaro J, Gomes J, Law C. Therapeutic substitution at a pediatric institution: an evaluation. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.
Hoffman M, Gomes J, Law C. Safety and formulary compliance with parenteral hydantoin anticonvulsant agents in pediatric patients. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.
Greene LA, Law C, Jung M, Walton S, Raffini LJ. Lack of Anti-Xa Assay Standardization Results in Significant Dose Variation in Neonates and Children Receiving Enoxaparin. Poster presented at the 55th (2013) American Society of Hematology Annual Meeting and Exposition, New Orleans, LA.
Hummel K, Law C, Le KM, Erush SC. Standardizing the necessity for off-label informed consent: A pediatric undertaking. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.
Gembarski J, Law C. Dexmedetomidine use in a pediatric population. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.
Isaacs L, Law C. Safety of the use of isoflurane in the pediatric intensive care unit. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.
Ravi S, Law C. Review of Sedation Medication-Related Respiratory Adverse Drug Events at a Pediatric Institution. Poster presented at the 46th (2011) ASHP Midyear Clinical Meeting & Exhibition, Anaheim, CA.
American College of Clinical Pharmacy (ACCP)
American Society of Health-System Pharmacists (ASHP)
Mid-Atlantic College of Clinical Pharmacy (MACCP)